title: Nanoparticles as synthetic vaccines.
abstract: As vaccines have transitioned from the use of whole pathogens to only the required antigenic epitopes, unwanted side effects have been decreased, but corresponding immune responses have been greatly diminished. To enhance immunogenicity, a variety of controlled release vehicles have been proposed as synthetic vaccines, but nanoparticles have emerged as particularly impressive systems due to many exciting publications. In specific, nanoparticles have been shown capable of not only desirable vaccine release, but can also be targeted to immune cells of interest, loaded with immunostimulatory substances termed adjuvants, or even induce desirable immune activating effects on their own. In the present review, recent advances in the utilization of inorganic, polymeric, and biomolecular nanoparticles as synthetic vaccines are discussed.
authors: Department of Chemical Engineering, University of Missouri, Columbia, MO 65211, United States.
authors: Josiah D
authors: JD
authors: Smith
authors: Department of Chemical Engineering, University of Missouri, Columbia, MO 65211, United States.
authors: Logan D
authors: LD
authors: Morton
authors: Department of Chemical Engineering, University of Missouri, Columbia, MO 65211, United States. Electronic address: uleryb@missouri.edu.
authors: Bret D
authors: BD
authors: Ulery
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D000917:Antibody Formation; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage / Q000737:chemistry; D008823:Micelles; D053758:Nanoparticles / Q000008:administration & dosage* / Q000737:chemistry; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D008081:Liposomes; D008823:Micelles; D014614:Vaccines, Synthetic